← All stocks

Relay Therapeutics, Inc.

RLAY Net selling
CIK 0001812364 #1471 in the set updated 17 Sep 2026
Bought (12 mo)
$0.00
out of their own pocket, the only kind of buying there is
Sold (12 mo)
$129.02M
$5.86M on a plan · $4.79M straight out of an exercise
Sold at will
$118.37M
19 of 38 sales
Net
−$129.02M
−$118.37M against sales at will

By person

6 insiders · 38 transactions
Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
SVF Pauling (Cayman) Ltd entity
10% owner
$116.40M (1)
−$116.40M
21,904,963
10.00%
$414.88M
−21.5%
Catinazzo Thomas
Chief Financial Officer
$5.18M (16) scheduled
−$5.18M
122,851
0.0561%
$2.33M
−54.6%
Patel Sanjiv
President and CEO
$3.61M (5) scheduled
−$3.61M
1,605,951
0.7328%
$30.42M
−31.0%
Bergstrom Donald A
President, R&D
$2.36M (8) scheduled
−$2.36M
399,130
0.1821%
$7.56M
−10.1%
Rahmer Peter
See remarks
$1.47M (8) scheduled
−$1.47M
223,657
0.1021%
$4.24M
−34.8%
Adams Brian
Chief Legal Officer
371,472
0.1695%
$7.04M
+14.7%
Insider
Date
Role
Action
Shares
Price
Amount
Patel Sanjiv
8 Sep 2026
President and CEO
Sold on a plan
48,199
$18.94
$912.89K
Catinazzo Thomas
8 Sep 2026
Chief Financial Officer
Sold on a plan
17,717
$18.94
$335.56K
Bergstrom Donald A
8 Sep 2026
President, R&D
Sold on a plan
8,530
$18.97
$161.81K
Rahmer Peter
26 Aug 2026
See remarks
Sold on a plan
4,508
$20.03
$90.30K
Patel Sanjiv
17 Aug 2026
President and CEO
Sold on a plan
48,199
$20.33
$979.89K
Catinazzo Thomas
14 Aug 2026
Chief Financial Officer
Sold on a plan
17,717
$19.74
$349.73K
Patel Sanjiv
7 Jul 2026
President and CEO
Sold on a plan
48,199
$19.58
$943.74K
Catinazzo Thomas
6 Jul 2026
Chief Financial Officer
Sold on a plan
17,717
$18.69
$331.13K
Bergstrom Donald A
6 Jul 2026
President, R&D
Sold on a plan
8,660
$18.71
$162.03K
Rahmer Peter
30 Jun 2026
See remarks
Sold on a plan
50,000
$19.09
$954.50K
Catinazzo Thomas
14 May 2026
Chief Financial Officer
Sold on a plan
17,717
$12.86
$227.84K
Catinazzo Thomas
7 Apr 2026
Chief Financial Officer
Sold on a plan
17,717
$13.01
$230.50K
Catinazzo Thomas
9 Mar 2026
Chief Financial Officer
Sold on a plan
17,717
$10.06
$178.23K

What was left out

Form 4 filings counted 43
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 1
Sales on a Rule 10b5-1 plan 13
Sales straight out of an exercise 6
Sales at will 19
Transactions with no price 0
Shares from compensation/vesting 272,802
History held since 20 Jul 2020